These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 452220)
1. Combination radiotherapy and chemotherapy in murine bladder cancer. Weldon TE; Kursh E; Novak LJ; Persky L Urology; 1979 Jul; 14(1):47 52. PubMed ID: 452220 [TBL] [Abstract][Full Text] [Related]
2. Radiation Therapy and cis-diammine-dichloroplatinum (II) in transplantable and primary murine bladder cancer. Soloway MS; Morris CR; Sudderth B Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1355-60. PubMed ID: 575119 [No Abstract] [Full Text] [Related]
3. The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinoma. Haas GP; Klugo RC; Hetzel FW; Barton EE; Cerny JC J Urol; 1984 Oct; 132(4):828-33. PubMed ID: 6540817 [TBL] [Abstract][Full Text] [Related]
4. Radiation therapy of experimental murine bladder cancer - synergism with cisplatinum diamminedichloride. Soloway MS; Gehrki G Surg Forum; 1977; 28():559-61. PubMed ID: 617536 [No Abstract] [Full Text] [Related]
5. Intravesical and systemic chemotherapy of murine bladder cancer. Soloway MS Cancer Res; 1977 Aug; 37(8 Pt 2):2918-29. PubMed ID: 406041 [No Abstract] [Full Text] [Related]
6. Single and combination chemotherapy for primary murine bladder cancer. Soloway MS Cancer; 1975 Aug; 36(2):333-40. PubMed ID: 1157004 [TBL] [Abstract][Full Text] [Related]
7. The effect of platinum analogues and combination chemotherapy on murine bladder cancer. Soloway MS; Cox CE Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820 [TBL] [Abstract][Full Text] [Related]
8. Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice. Kyriazis AP; Yagoda A; Kereiakes JG; Kyriazis AA; Whitmore WF Cancer; 1983 Aug; 52(3):452-7. PubMed ID: 6683120 [TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report. Sternberg JJ; Bracken RB; Handel PB; Johnson DE JAMA; 1977 Nov; 238(21):2282-7. PubMed ID: 578848 [TBL] [Abstract][Full Text] [Related]
10. Effect of chemotherapeutic agents on bladder cancer: a new animal model. Soloway MS; deKernion JB; Rose D; Persky L Surg Forum; 1973; 24():542-4. PubMed ID: 4806091 [No Abstract] [Full Text] [Related]
11. Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. Merrin C; Cartagena R; Wajsman Z; Baumgartner G; Murphy GP J Urol; 1975 Dec; 114(6):884-7. PubMed ID: 1195468 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of bladder cancer: current status and prospects. Smith WK; Koontz WW Va Med; 1979 Feb; 106(2):131-4. PubMed ID: 425674 [No Abstract] [Full Text] [Related]
13. Systemic therapy of bladder cancer. Salem PA Prog Clin Biol Res; 1984; 162B():95-105. PubMed ID: 6209726 [No Abstract] [Full Text] [Related]
14. Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer. Hickey DP; Brausi M; Blatnik AF; Soloway MS Urology; 1987 Nov; 30(5):484-7. PubMed ID: 3118551 [TBL] [Abstract][Full Text] [Related]